Home » Authors » Brady Huggett

Articles by Brady Huggett

Biopure, Others Remain On Long Road With 'Oxygen Therapeutics'

Jan. 24, 2005

By Brady Huggett

Serologicals Raises $127M, Adds To 2004's Money Total

Dec. 17, 2004

By Brady Huggett

Serologicals Raises $127M, Adds To 2004's Money Total

Dec. 17, 2004

By Brady Huggett

Vitex Downsizing By 40 Percent, Raising $20M If Merger Closes

Dec. 13, 2004

By Brady Huggett

Vitex Downsizing By 40 Percent, Raising $20M If Merger Closes

Dec. 13, 2004

By Brady Huggett

Dynavax's Phase II/III HBV Data Supportive; Phase III Trials Next

Dec. 10, 2004

By Brady Huggett

Dynavax's Phase II/III HBV Data Supportive; Phase III Trials Next

Dec. 10, 2004

By Brady Huggett

Preos Data AT ACR Nicks NPS, But Anabolic Market 'Growing'

Oct. 25, 2004

By Brady Huggett

Preos Data AT ACR Nicks NPS, But Anabolic Market 'Growing'

Oct. 25, 2004

By Brady Huggett

After Flu Vaccine Mess, Chiron's Q3 Earnings 'Almost Irrelevant'

Oct. 22, 2004

By Brady Huggett

Chiron Corp. released its third-quarter earnings Wednesday, and while those figures were better than expected, the Fluvirin disaster has faded their importance. (BioWorld Today)